...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Antibacterial synergy of Tritirachium oryzae-produced silver nanoparticles with different antibiotics and essential oils derived from Cupressus sempervirens and Asteriscus graveolens (Forssk)
【24h】

Antibacterial synergy of Tritirachium oryzae-produced silver nanoparticles with different antibiotics and essential oils derived from Cupressus sempervirens and Asteriscus graveolens (Forssk)

机译:米曲霉产生的银纳米颗粒与不同的抗生素和精油的协同作用,这些精油来自柏(Cupressus sempervirens)和紫草(Forssk)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To carry out eco-friendly biosynthesis of fungi-derived silver nanoparticles (AgNPs) and investigate their antibacterial synergies with essential oils (EOs) of Asteriscus graveolens (Forssk.) Less. and Cupressus sempervirens. Methods: Biosynthesis of AgNPs was carried out using a cell-free filtrate of Tritirachium oryzae. The biosynthesized AgNPs characteristics were assessed using different methods, including ultraviolet-visible spectrophotometry (UV), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) with energy-dispersive x-ray spectroscopy (EDS) and transmission electron microscopy (TEM). Results: Obvious synergistic effects were observed between AgNPs and chloramphenicol, vancomycin, nitrofurantoin or tetracycline with Pseudomonas aeruginosa, through increases in fold area of inhibition (IFAs) within the range of 2.4 to 9.0. Synergistic interactions were also seen between AgNPs and the antibiotics used, depending on the strain. Increase in IFA ranged from 1- to 3-fold for S. aureus, E. coli and P. aeruginosa. Similarly, combinations of AgNPs, EO of A. graveolens and cefotaxime, nitrofurantoin or amoxicillin against P. aeruginosa led to 10-, 3- and 10-fold synergy, respectively. In contrast, the use of AgNPs and trimethoprim, tetracycline or amoxicillin against E. coli led to 1 to 6-fold synergy. The best synergistic capacity resulted from AgNPs and the EO of C. sempervirens and trimethoprim against S. epidermidis, which yielded 29-fold increase in IFA. The use of combination of AgNPs and vancomycin against P. aeruginosa led to 16.4-fold enhancement of IFA. Conclusion: The findings can potentially lead to the development of a new perception of antibacterial agents (innovative medications) involving the incorporation of nanoparticles (NPs) or new materials that potentially synergize with antibiotics, NPs and the EOs of different plants.
机译:目的:进行真菌衍生的银纳米颗粒(AgNPs)的生态友好型生物合成,并研究它们与紫草(Forssk。)精油(EOs)的抗菌协同作用。和柏(Cpressus sempervirens)。方法:使用无细胞的米曲霉的滤液进行AgNPs的生物合成。使用不同的方法评估了生物合成的AgNPs特性,包括紫外可见分光光度法(UV),傅立叶变换红外光谱(FTIR),扫描电子显微镜(SEM)和能量色散X射线光谱(EDS)和透射电子显微镜( TEM)。结果:通过在2.4到9.0范围内增加抑制倍数(IFAs),AgNP与氯霉素,万古霉素,硝基呋喃妥因或四环素与铜绿假单胞菌之间具有明显的协同作用。根据菌株的不同,在AgNPs和使用的抗生素之间还发现了协同作用。对于金黄色葡萄球菌,大肠杆菌和铜绿假单胞菌,IFA的增加范围是1到3倍。同样,AgNPs,A.gravolens的EO和头孢噻肟,硝基呋喃妥因或阿莫西林对铜绿假单胞菌的组合分别导致10倍,3倍和10倍协同作用。相反,使用AgNP和甲氧苄氨嘧啶,四环素或阿莫西林对抗大肠杆菌会产生1至6倍的协同作用。最佳的协同能力是由AgNPs和s.sempervirens的EO和甲氧苄啶对表皮葡萄球菌造成的,其IFA增加了29倍。 AgNP和万古霉素联合使用抗铜绿假单胞菌导致IFA增强16.4倍。结论:这些发现可能会导致对抗菌剂(创新药物)的新认识,涉及掺入纳米颗粒(NP)或可能与不同植物的抗生素,NP和EO协同作用的新材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号